CS logo
small CS logo
Michael H. Tirgan, MD

New York, New York, United States
Oncologist in New York City, New York
23 W 73rd St, Suite GD, New York, NY 10023

About Michael H. Tirgan, MD


"Dr. Tirgan is the only physician in North America whose medical practice and research is dedicated solely to the treatment of keloid patients. For the past several years, Dr. Tirgan has provided medical care and keloid treatment to over 1,600 keloid patients, many of whom traveled to New York from far away places."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Tirgan, Michael H., M.D.
8
Total Rows: 1

Clinical Trials at Michael H. Tirgan, MD


During the past decade, Michael H. Tirgan, MD conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails201600.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue
2012-02-01
2012-11-01
Terminated
2
Epidemiology Study of Keloid
2011-09-01
2021-12-01
Unknown status
100,000
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
2011-11-01
2031-06-01
Recruiting
10,000
Sorafenib for Patients With Extensive Keloids
2013-03-01
2013-03-01
Terminated
60
Keloid Tissue Bank
2012-06-01
2018-12-01
Terminated
78
Keloid Radiation Registry
2011-12-01
2021-06-01
Unknown status
1,000
Study of Psycho-Social Impact of Keloid
2012-09-01
2012-09-01
Terminated
1,000
Retrospective Study of Keloid Disorder
2016-09-01
2023-09-01
Recruiting
5,000

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsTirgan, Michael H., M.D.: 8Tirgan, Michael H., M.D.: 8

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Michael H. Tirgan, MD


According to Clinical.Site data, the most researched conditions in "Michael H. Tirgan, MD" are "Keloid" (7 trials) and "Keloids" (1 trials). Many other conditions were trialed in "Michael H. Tirgan, MD" in a lesser frequency.

Clinical Trials Intervention Types at Michael H. Tirgan, MD


Most popular intervention types in "Michael H. Tirgan, MD" are "Biological" (1 trials), "Drug" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "History of Radiation Therapy" (1 trials), "History of prior Surgery" (1 trials), "Sorafenib" (1 trials) and "bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Michael H. Tirgan, MD


The vast majority of trials in "Michael H. Tirgan, MD" are 8 trials for "All" genders.

Clinical Trials Status at Michael H. Tirgan, MD


Currently, there are NaN active trials in "Michael H. Tirgan, MD". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Michael H. Tirgan, MD, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Michael H. Tirgan, MD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusTerminated: 4Terminated: 4Recruiting: 2Recruiting: 2Unknown status: 2Unknown status: 2